Outpatient management of croup

Terry P. Klassen, Peter Rowe

Research output: Contribution to journalArticle

Abstract

Now that there is widespread acceptance of glucocorticoids for inpatient treatment of croup, the focus of research has shifted to the effectiveness of glucocorticoids for outpatients with croup. Recent evidence from randomized controlled trials has shown that nebulized budesonide causes an acute improvement in croup symptoms, shortens stay in the emergency department, and significantly reduces admission rate. Intramuscular or oral dexamethasone also result in acute clinical improvement in patients with croup, and oral dexamethasone reduces the length of stay in an emergency department observation unit. There is accumulating evidence that patients receiving epinephrine do not necessarily require hospitalization but when treated simultaneously with dexamethasone may be safely discharged to home after a 3- hour observation period. Future trials in outpatients with croup need to determine the optimal dosing of oral dexamethasone, the utility of epinephrine therapy alone or in combination with glucocorticoids, and the optimal glucocorticoid regimen (budesonide, dexamethasone, or budesonide and dexamethasone).

Original languageEnglish (US)
Pages (from-to)449-452
Number of pages4
JournalCurrent Opinion in Pediatrics
Volume8
Issue number5
StatePublished - 1996

Fingerprint

Croup
Dexamethasone
Outpatients
Glucocorticoids
Budesonide
Epinephrine
Hospital Emergency Service
Observation
Inpatients
Length of Stay
Hospitalization
Randomized Controlled Trials
Therapeutics
Research

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Outpatient management of croup. / Klassen, Terry P.; Rowe, Peter.

In: Current Opinion in Pediatrics, Vol. 8, No. 5, 1996, p. 449-452.

Research output: Contribution to journalArticle

Klassen, TP & Rowe, P 1996, 'Outpatient management of croup', Current Opinion in Pediatrics, vol. 8, no. 5, pp. 449-452.
Klassen, Terry P. ; Rowe, Peter. / Outpatient management of croup. In: Current Opinion in Pediatrics. 1996 ; Vol. 8, No. 5. pp. 449-452.
@article{e6441a621de74d0997a1ee1c71ef630a,
title = "Outpatient management of croup",
abstract = "Now that there is widespread acceptance of glucocorticoids for inpatient treatment of croup, the focus of research has shifted to the effectiveness of glucocorticoids for outpatients with croup. Recent evidence from randomized controlled trials has shown that nebulized budesonide causes an acute improvement in croup symptoms, shortens stay in the emergency department, and significantly reduces admission rate. Intramuscular or oral dexamethasone also result in acute clinical improvement in patients with croup, and oral dexamethasone reduces the length of stay in an emergency department observation unit. There is accumulating evidence that patients receiving epinephrine do not necessarily require hospitalization but when treated simultaneously with dexamethasone may be safely discharged to home after a 3- hour observation period. Future trials in outpatients with croup need to determine the optimal dosing of oral dexamethasone, the utility of epinephrine therapy alone or in combination with glucocorticoids, and the optimal glucocorticoid regimen (budesonide, dexamethasone, or budesonide and dexamethasone).",
author = "Klassen, {Terry P.} and Peter Rowe",
year = "1996",
language = "English (US)",
volume = "8",
pages = "449--452",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Outpatient management of croup

AU - Klassen, Terry P.

AU - Rowe, Peter

PY - 1996

Y1 - 1996

N2 - Now that there is widespread acceptance of glucocorticoids for inpatient treatment of croup, the focus of research has shifted to the effectiveness of glucocorticoids for outpatients with croup. Recent evidence from randomized controlled trials has shown that nebulized budesonide causes an acute improvement in croup symptoms, shortens stay in the emergency department, and significantly reduces admission rate. Intramuscular or oral dexamethasone also result in acute clinical improvement in patients with croup, and oral dexamethasone reduces the length of stay in an emergency department observation unit. There is accumulating evidence that patients receiving epinephrine do not necessarily require hospitalization but when treated simultaneously with dexamethasone may be safely discharged to home after a 3- hour observation period. Future trials in outpatients with croup need to determine the optimal dosing of oral dexamethasone, the utility of epinephrine therapy alone or in combination with glucocorticoids, and the optimal glucocorticoid regimen (budesonide, dexamethasone, or budesonide and dexamethasone).

AB - Now that there is widespread acceptance of glucocorticoids for inpatient treatment of croup, the focus of research has shifted to the effectiveness of glucocorticoids for outpatients with croup. Recent evidence from randomized controlled trials has shown that nebulized budesonide causes an acute improvement in croup symptoms, shortens stay in the emergency department, and significantly reduces admission rate. Intramuscular or oral dexamethasone also result in acute clinical improvement in patients with croup, and oral dexamethasone reduces the length of stay in an emergency department observation unit. There is accumulating evidence that patients receiving epinephrine do not necessarily require hospitalization but when treated simultaneously with dexamethasone may be safely discharged to home after a 3- hour observation period. Future trials in outpatients with croup need to determine the optimal dosing of oral dexamethasone, the utility of epinephrine therapy alone or in combination with glucocorticoids, and the optimal glucocorticoid regimen (budesonide, dexamethasone, or budesonide and dexamethasone).

UR - http://www.scopus.com/inward/record.url?scp=0029959695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029959695&partnerID=8YFLogxK

M3 - Article

C2 - 8946123

AN - SCOPUS:0029959695

VL - 8

SP - 449

EP - 452

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 5

ER -